» Articles » PMID: 32446946

The Effects of Inhaled Sodium Nitrite on Pulmonary Vascular Impedance in Patients With Pulmonary Hypertension Associated with Heart Failure With Preserved Ejection Fraction

Overview
Journal J Card Fail
Date 2020 May 25
PMID 32446946
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The severity of pulmonary hypertension (PH) is monitored by measuring pulmonary vascular resistance, which is a steady-state measurement and ignores the pulsatile load encountered by the right ventricle (RV). Pulmonary vascular impedance (PVZ) can depict both steady-state and pulsatile forces, and thus may better predict clinical outcomes. We sought to calculate PVZ in patients with PH associated with heart failure with preserved ejection fraction who were administered inhaled sodium nitrite to better understand the acute effects on afterload.

Methods And Results: Fourteen patients with PH associated with heart failure with preserved ejection fraction underwent right heart catherization and were administered inhaled sodium nitrite. A Fourier transform was used to calculate PVZ for both before and after nitrite for comparison. Inhaled sodium nitrite decreased characteristic impedance (inversely related to proximal pulmonary artery compliance) and total work performed by the RV. RV efficiency improved, defined by a reduction in the total work divided by cardiac output. There was a mild decrease in pulmonary steady-state resistance after the administration of inhaled sodium nitrite, but this effect was not significant.

Conclusions: PVZ analysis showed administration of inhaled sodium nitrite was associated with an improvement in pulmonary vascular compliance via a decrease in characteristic impedance, more so than pulmonary steady-state resistance. This effect was associated with improved RV efficiency and total work.

Citing Articles

Effectiveness and safety of the use of sodium nitrite in patients with hypertension and pulmonary hypertension: a scoping review.

Ribeiro J, Santana A, de Oliveira Marusso L, de Oliveira Marrafon D, Dos Reis T, Rosalen P Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39873718 DOI: 10.1007/s00210-025-03796-7.


Pulmonary Hypertension in Heart Failure.

Jang A, Park S, Chung W Int J Heart Fail. 2022; 3(3):147-159.

PMID: 36262642 PMC: 9536651. DOI: 10.36628/ijhf.2020.0053.


Skeletal Muscle Contractile Function in Heart Failure With Reduced Ejection Fraction-A Focus on Nitric Oxide.

Park L, Coggan A, Peterson L Front Physiol. 2022; 13:872719.

PMID: 35721565 PMC: 9198547. DOI: 10.3389/fphys.2022.872719.


Semi-Automated Graphical System for Calculating Pulmonary Vascular Impedances in a Clinical Setting.

Bachman T, Kim K, Simon M IEEE Open J Eng Med Biol. 2022; 2:198-200.

PMID: 35402985 PMC: 8979623. DOI: 10.1109/OJEMB.2021.3076726.


Current Understanding of the Right Ventricle Structure and Function in Pulmonary Arterial Hypertension.

Kia D, Kim K, Simon M Front Physiol. 2021; 12:641310.

PMID: 34122125 PMC: 8194310. DOI: 10.3389/fphys.2021.641310.